Back to Search
Start Over
Involvement of p53 and interleukin 3 in the up-regulation of CD95 (APO-1/Fas) by X-ray irradiation
- Source :
- Oncogene. 19:3647-3655
- Publication Year :
- 2000
- Publisher :
- Springer Science and Business Media LLC, 2000.
-
Abstract
- Interleukin 3-dependent bone marrow and Ba/F3 cells present constitutive Fas expression. A dose dependent increase in Fas surface expression was induced in these cells by X-ray irradiation. Using primary cell cultures and established cell lines derived from p53-null mice (p53-/-), we demonstrated that the increase in Fas expression upon X-ray irradiation is dependent on the presence of at least one wild-type p53 allele. Fas induction by X-ray irradiation was negatively modulated by IL-3; an earlier Fas induction was observed in the absence of IL-3 or at low IL-3 concentrations. However, IL-3 withdrawal in non-irradiated cells did not induce an increase in Fas expression. X-ray irradiation of Ba/F3 cells induced the expression of functional Fas receptors. Therefore, in IL-3-dependent cells, IL-3 regulates the rate of Fas expression, which is correlated with the degree of apoptosis observed in X-irradiated cells. Finally, we demonstrate that IL-3 controls the degree of Fas expression induced by irradiation through a p53-mediated pathway.
- Subjects :
- Cancer Research
medicine.medical_specialty
Time Factors
Bone Marrow Cells
Biology
Mice
Downregulation and upregulation
Internal medicine
Gene expression
Tumor Cells, Cultured
Genetics
medicine
Animals
fas Receptor
Molecular Biology
Cells, Cultured
Interleukin 3
Mice, Knockout
Cell Membrane
Interleukin
Fas receptor
Molecular biology
Up-Regulation
Mice, Inbred C57BL
Endocrinology
medicine.anatomical_structure
Cell culture
Apoptosis
Interleukin-3
Bone marrow
Tumor Suppressor Protein p53
Subjects
Details
- ISSN :
- 14765594 and 09509232
- Volume :
- 19
- Database :
- OpenAIRE
- Journal :
- Oncogene
- Accession number :
- edsair.doi.dedup.....821b23d0bea9cba7eb31ba0644712cf6
- Full Text :
- https://doi.org/10.1038/sj.onc.1203662